|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0032744,
umls-concept:C0038952,
umls-concept:C0205210,
umls-concept:C0205289,
umls-concept:C0233929,
umls-concept:C0302995,
umls-concept:C0332291,
umls-concept:C0681842,
umls-concept:C0872172,
umls-concept:C1515169,
umls-concept:C1521733,
umls-concept:C1521996,
umls-concept:C2348529
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-5-29
|
|
pubmed:abstractText |
Positron emission tomographic maximal standardized uptake value has been shown to predict survival after resection of non-small cell lung cancer. The relative prognostic benefit of maximal standardized uptake value with respect to other clinical/pathologic variables has not been defined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1097-685X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
133
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1419-27
|
|
pubmed:meshHeading |
pubmed-meshheading:17532932-Adult,
pubmed-meshheading:17532932-Aged,
pubmed-meshheading:17532932-Aged, 80 and over,
pubmed-meshheading:17532932-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17532932-Chi-Square Distribution,
pubmed-meshheading:17532932-Female,
pubmed-meshheading:17532932-Fluorodeoxyglucose F18,
pubmed-meshheading:17532932-Humans,
pubmed-meshheading:17532932-Lung Neoplasms,
pubmed-meshheading:17532932-Male,
pubmed-meshheading:17532932-Middle Aged,
pubmed-meshheading:17532932-Neoplasm Staging,
pubmed-meshheading:17532932-Positron-Emission Tomography,
pubmed-meshheading:17532932-Predictive Value of Tests,
pubmed-meshheading:17532932-Proportional Hazards Models,
pubmed-meshheading:17532932-Radiopharmaceuticals,
pubmed-meshheading:17532932-Retrospective Studies,
pubmed-meshheading:17532932-Survival Analysis
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.
|
|
pubmed:affiliation |
Thoracic Surgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. downeyr@mskcc.org
|
|
pubmed:publicationType |
Journal Article
|
